A, K., S, P., J, M., S, M., & D, A. (2026). Systemic Inflammation as a Modulator of FcRn-dependent IgG Pharmacokinetics: Implications for Broadly Neutralising Antibody Efficacy in HIV Prevention. Current HIV/AIDS reports, 23(1), . https://doi.org/10.1007/s11904-026-00791-2
Chicago Style (17th ed.) CitationA, Khumalo, Pillay S, Mohan J, Mahomed S, and Archary D. "Systemic Inflammation as a Modulator of FcRn-dependent IgG Pharmacokinetics: Implications for Broadly Neutralising Antibody Efficacy in HIV Prevention." Current HIV/AIDS Reports 23, no. 1 (2026). https://doi.org/10.1007/s11904-026-00791-2.
MLA (9th ed.) CitationA, Khumalo, et al. "Systemic Inflammation as a Modulator of FcRn-dependent IgG Pharmacokinetics: Implications for Broadly Neutralising Antibody Efficacy in HIV Prevention." Current HIV/AIDS Reports, vol. 23, no. 1, 2026, https://doi.org/10.1007/s11904-026-00791-2.